You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 821 The combination of a trastuzumab ISAC and pertuzumab augments anti-tumor efficacy in multiple HER2+ tumor models relative to trastuzumab plus pertuzumab

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Combination Immunotherapies
821 The combination of a trastuzumab ISAC and pertuzumab augments anti-tumor efficacy in multiple HER2+ tumor models relative to trastuzumab plus pertuzumab

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023184026
Dec 20234407
Jan 20245306
Feb 20244202
Mar 20245009
Apr 20244203
May 20245604
Jun 20242800
Jul 20243002
Aug 20241402
Sep 20243401
Oct 20243809
Nov 20244608
Dec 20242802
Jan 20251908
Feb 2025605
Mar 2025002
Apr 2025007
May 2025004
Jun 2025105
Total7150112